Finally, we assessed the effect of rfhSP-D on mTORC1 activity by measuring the phosphorylation status of S6 Kinase (S6K) since an increase in S6K phosphorylation is a sign of an active mTOR pathway and has been evidenced in late stage ovarian cancer (19). This evidence concerns the gene MTOR and ovarian cancer.